Epstein Becker Green (EBG) provided regulatory counsel to a private equity firm in its multibillion-dollar bid to acquire a leading provider of institutional review board, institutional biosafety committee, and compliance and regulatory consulting services in the United States and Canada. EBG provided regulatory due diligence of the target’s operations to assess federal and state health care regulatory compliance risks.
Results may vary depending on your particular facts and legal circumstances.